Matthew was Vice President, Clinical Development and Medical Affairs, Specialty Care at Boehringer Ingelheim, and Vice President and Head of Immunology and Dermatology Medical Unit at Novartis. Matthew Frankel joined Chemomab in 2022.
Matthew Frankel is currently Chief Medical Officer and Vice President of Drug Development at Chemomab - View - Chemomab org chart
Create your alert
to follow the career of Matthew Frankel.
Matthew Frankel has a Doctor of Medicine from University of California, Los Angeles and a Master of Business Administration in finance and marketing from Northwestern University - Kellogg School of Management.
They have also studied at University of California, Los Angeles :
Find more alumni from University of California, Los Angeles
They have also studied at Northwestern University - Kellogg School of Management :
Find more alumni from Northwestern University - Kellogg School of Management
Do you need to know more about Matthew Frankel? More results.
Report an error
Update the org chart details of Matthew Frankel.
Sorry, but Matthew Frankel cannot be contacted yet through our email service. Please use our Premium/VIP service to join colleagues of Matthew Frankel listed below. Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.